Navigation Links
Masimo to Present at Goldman Sachs 29th Annual Global Healthcare Conference
Date:6/3/2008

IRVINE, Calif., June 3 /PRNewswire-FirstCall/ -- Masimo Corporation (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through-Motion-and-Low-Perfusion pulse oximetry, today announced that it is scheduled to present at the Goldman Sachs 29th Annual Global Healthcare Conference at The Ritz Carlton, Laguna Nigel, in Dana Point, CA, on Wednesday, June 11, 2008, at 2:40 p.m. PT. Joe E. Kiani, Chairman and CEO, will be presenting.

A live audiocast of the presentation will be available on the Masimo website at http://www.masimo.com. A replay of the audiocast will be available following the live presentation.

About Masimo

Masimo (Nasdaq: MASI) develops innovative monitoring technologies that significantly improve patient care-helping solve "unsolvable" problems. In 1995, the company debuted Measure-Through-Motion-and-Low-Perfusion pulse oximetry, known as Masimo SET, which virtually eliminated false alarms and increased pulse oximetry's ability to detect life-threatening events. More than 100 independent and objective studies demonstrate Masimo SET provides the most reliable SpO2 and pulse rate measurements even under the most challenging clinical conditions, including patient motion and low peripheral perfusion. In 2005, Masimo introduced Masimo Rainbow SET, a breakthrough noninvasive blood constituent monitoring platform that can measure many blood constituents that previously required invasive procedures. Masimo Rainbow SET continuously
'/>"/>

SOURCE Masimo Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Masimo to Present at Deutsche Bank 33rd Annual Health Care Conference
2. Masimo Reports First Quarter 2008 Financial Results
3. Atom Medical Adopts Masimo Rainbow SET Technology
4. Schiller AG Adopts Masimo Rainbow SET as Their Technology Platform of Choice for Patient Monitoring Devices Worldwide
5. Masimo to Present at Citi Investment Research 5th Annual Small & Mid-Cap Conference
6. Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results
7. Masimo Announces Continuous Noninvasive Total Hemoglobin
8. Masimo Awarded Multi-Year Pulse Oximetry Agreement with HealthTrust Purchasing Group
9. Abington Memorial Hospital Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology
10. Masimo Corporation Given Approval to Market the Masimo Rad-57 Pulse CO-Oximeter in Japan
11. Masimo to Report Third Quarter 2007 Financial Results on October 30, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2008)...Newswire-FirstCall/ -- BioForm Medical,Inc. (Nasd...for the fourth,quarter and full fiscal year ended ...e quarter ended June 30, 2008 as compared to $15.4...ncrease of $1.3 million or 8.4%.,The net loss was ...as,compared to a net loss of $4.9 million for the ...
(Date:9/4/2008)... 4 /-, - Prevenar Vaccine ...ne-Preventable Cause of Death in Young Children Wo...e Republic of Ireland have,initiated national immu...hildren against pneumococcal disease by adding Pre...ine, Adsorbed), also called PCV7, to their,nationa...
(Date:9/4/2008)...niversity of North Carolina-Chapel Hill Anno...ces, RESEARCH TRIANGLE PARK, N.C., Sept. 4 /PRNew...s and the University of North Carolina at,Chapel H... for Drug Safety,Sciences that will be led by Dr. ...n drug-induced liver injury. As founding director ...
(Date:9/4/2008)...Commercialization of Recently FDA-cleared ...YVALE, Calif., Sept. 4 /- Pathwork Di... on oncology, announced the closing,today of a $20...ment came,on the heels of FDA,s clearance for the ... tumors of uncertain origin, including poorly,diff...
Breaking Biology Technology:BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 2BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 3BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 4BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 5BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 6BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 7BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 8BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 9Cyprus and Ireland Add Wyeth's 7-Valent Pneumococcal Conjugate Vaccine (PCV7) to Their National Immunisation Schedules 2Cyprus and Ireland Add Wyeth's 7-Valent Pneumococcal Conjugate Vaccine (PCV7) to Their National Immunisation Schedules 3New Hamner-UNC Center for Drug Safety Sciences 2New Hamner-UNC Center for Drug Safety Sciences 3Pathwork Diagnostics Closes $20M Financing 2
...ad Part 1 . Winslow Sargeants combination of acad...im rare insight into the world of entrepreneurship...r remind him that to succeed at anything, tenacity...far removed from the place Sargeant knew as a chil...hur Garrity, Jr. ordered massive busing throughout...
...16 percent the past two years, Wisconsin,s bioscie...ically known for beer, brats, and milk, says Gale ...released today at the State Capitol in Madison. ,...ing that fast?" she asked. Davy is the executive d...al Research & Education , a non-profit group spons...
...Wisconsin company specializing in functional Magne..., announced today that the Food and Drug Administr...arket clearance of its trademarked MindState fDAD.... in February 2005 as an fMRI data acquisition devi...ance fDAD by providing a library of stimulation pa...
...ectorConnector , that connects businesses and non-...is up to 500 registered users, according to the tw...hael Best & Friedrich, LLP and the accounting fi...to connect organizations in need of specially-skil...idates. Recent surveys indicate that directors are...
Other Biology Technology:Winslow Sargeant: Stepping onto the train called Wisconsin - Part 2 2Winslow Sargeant: Stepping onto the train called Wisconsin - Part 2 3Winslow Sargeant: Stepping onto the train called Wisconsin - Part 2 4Bioscience beats beer 2
(Date:9/3/2008)...lm Vein Recognition Solution Named the Winner in t...ealthcare Category, SUNNYVALE, Calif., Sept. 3 /P..., Inc., a leading supplier of innovative computer ...nd biometric security solutions, announced,today t...on was named the,winner in the Best Security Solut...
(Date:9/3/2008)...NNE, Ill. (Sept. 3, 2008) Scientists at the U.S. ...ratory have won an $800,000 EUREKA award from the ...MAX, a precise molecular ruler for measuring dista...for the Multi-wavelength Anomalous Diffraction usi...ot only dramatically reduce the time necessary to ...
(Date:9/3/2008)...FAX, Va.Ten million Americans have peripheral arte...ghest risk populations include African-Americans (...seniors (12-20 percent develop PAD) and diabetics ...AD). Legs for Lifea community health and public in...ake its free, online self-assessment quiz. , The...
(Date:9/3/2008)...ation in the gene for one of the receptors for the... how human males bond with their partners, accordi...The researchers found that the "334" allele of a c...a studied in voles, seemed to have negative effect...Our findings are particularly interesting because ...
Breaking Biology News(10 mins):Fujitsu PalmSecure(TM) Wins Network Products Guide 2008 Reader Trust Award 2Fujitsu PalmSecure(TM) Wins Network Products Guide 2008 Reader Trust Award 3NIH awards Argonne $800,000 to develop tool to measure distances within proteins 2At risk for peripheral arterial disease? Simple quiz provides key so you can circulate better 2At risk for peripheral arterial disease? Simple quiz provides key so you can circulate better 3Gene associated with pair-bonding in animals has similar effects in human males 2Gene associated with pair-bonding in animals has similar effects in human males 3Celldex Therapeutics Receives Fast Track Designation for CDX 110 a Novel EGFRvIII Vaccine for Glioblastoma 1143 1Celldex Therapeutics Receives Fast Track Designation for CDX 110 a Novel EGFRvIII Vaccine for Glioblastoma 1143 2Celldex Therapeutics Receives Fast Track Designation for CDX 110 a Novel EGFRvIII Vaccine for Glioblastoma 1143 3Celldex Therapeutics Receives Fast Track Designation for CDX 110 a Novel EGFRvIII Vaccine for Glioblastoma 1143 4Celldex Therapeutics Receives Fast Track Designation for CDX 110 a Novel EGFRvIII Vaccine for Glioblastoma 1143 5Difficult to Treat Erectile Dysfunction Patients 2474 1Difficult to Treat Erectile Dysfunction Patients 2474 2Difficult to Treat Erectile Dysfunction Patients 2474 3A special issue of the International Journal of Plant Sciences 1788 1A special issue of the International Journal of Plant Sciences 1788 2A special issue of the International Journal of Plant Sciences 1788 3UCLA scientists restore walking after spinal cord injury 9123 1UCLA scientists restore walking after spinal cord injury 9123 2UCLA scientists restore walking after spinal cord injury 9123 3
... family,s ancestors roamed 60,000 years ago? ,Now ...ost ambitious project tracing the genetic and migr...general public from all over the world can supply ...ts at The University of Arizona in Tucson will do ...art of a larger undertaking to unravel the origins...
...ter it burst onto the scene, HIV/AIDS has claimed ...vastate societies around the world, particularly i...te 1980s and early 1990s, after years of effort AI...drugs that proved to be highly effective against A...HIV protease, these protease inhibitors brought gr...
...ffensive strategies can become weaknesses, if the ...its weapons. , By manipulating what is perhaps th...ox viruses like smallpox, Arizona State University...tram Jacobs believes that he can turn the biochemi...s ?and protect the public against catastrophic bio...
...l University Health Centre (MUHC), in Montreal, ha...w study, published in the on-line edition of the j...earchers document a reduction in the growth of bot...the gene. , The new target gene is called methylen... were able to inhibit the function of the gene by ...
Other Biology News:The biggest family tree ever 2The biggest family tree ever 3Supercomputers to focus brains on AIDS dilemma 2Supercomputers to focus brains on AIDS dilemma 3Supercomputers to focus brains on AIDS dilemma 4Secret of smallpox's success may lead to bioterror cure 2Secret of smallpox's success may lead to bioterror cure 3Secret of smallpox's success may lead to bioterror cure 4Secret of smallpox's success may lead to bioterror cure 5
... HistoMark Biotin Streptavidin-HRP Systems provide...ntracellular antigens in frozen or paraffin-embedd...e systems also facilitate double or triple labelei...ltaneously with primary antibodies of different an...
Polystyrene covers can be used with all 96-well plates Ridged covers for stacking of covered plates Non-ridged covers for use with automated systems Polypropylene covers, ridged and non-ridged,
SYBR Green Nucleic Acid Dye
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,670-7) or contact custom
Biology Products: